PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.\', \'Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland.\', \'Medical Faculty, University of Basel, Basel, Switzerland.\', \'Institute of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.\', \'Microbiology Innovation and Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK.\', \'University of Southampton, School of Medicine Tremona Road Southampton, Southampton, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1515/cclm-2020-1295
?:doi
?:hasPublicationType
?:journal
  • Clinical chemistry and laboratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 33554516
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.114
?:rankingScore_hIndex
  • 88
is ?:relation_isRelatedTo_publication of
?:title
  • The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33554516>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33554516>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all